Compare BCTXZ & SAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
| Metric | BCTXZ | SAX |
|---|---|---|
| Founded | N/A | N/A |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | | |
| Sector | | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | N/A | N/A |
| IPO Year | 2025 | 2006 |
| Metric | BCTXZ | SAX |
|---|---|---|
| Price | $0.20 | $24.89 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 93.7K | 37.0K |
| Earning Date | N/A | N/A |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 14.36 |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.06 | $24.72 |
| 52 Week High | $0.52 | $24.93 |
| Indicator | BCTXZ | SAX |
|---|---|---|
| Relative Strength Index (RSI) | 88.04 | N/A |
| Support Level | $0.13 | N/A |
| Resistance Level | $0.46 | N/A |
| Average True Range (ATR) | 0.04 | 0.00 |
| MACD | 0.01 | 0.00 |
| Stochastic Oscillator | 75.50 | 0.00 |
BriaCell Therapeutics Corp is a clinical-stage biotechnology company focused on developing immunotherapies for cancer treatment, particularly breast cancer. The company's targeted immunotherapy program, Bria-IMT, is a targeted cell-based immunotherapy in end-stage clinical trials aiming to improve outcomes for patients with breast cancer. BriaCell also develops Bria-OTS, personalized off-the-shelf immunotherapies for breast and prostate cancer. BriaCell is involved in clinical collaborations to explore combination therapies for enhanced cancer treatment options.